- Femasys Inc. (FEMY, Financial) has announced a public offering of common stock alongside a private placement.
- The company plans to use the proceeds for commercial expansion, product development, and other corporate purposes.
- Jones is the sole book-running manager for the public offering and placement agent for the private placement.
Femasys Inc. (NASDAQ: FEMY), a biomedical company dedicated to women's health, is set to raise capital through a proposed public offering of common stock and a concurrent private placement. The firm aims to issue additional shares, granting underwriters a 30-day option to purchase up to an additional 15% of the shares sold through the public offering.
The company has highlighted that existing institutional shareholders, directors, and officers have shown interest in participating in the private placement. Jones will manage both the public offering and the private placement as the sole book-running manager and placement agent, respectively.
Proceeds from these offerings will support Femasys' strategies for commercial expansion, product development, capital expenditures, and general corporate purposes. The public offering will proceed under a previously filed S-3 Registration Statement, while the private placement will utilize exemptions under the Securities Act.
Investors should be aware that the completion and terms of both the public offering and private placement are subject to prevailing market conditions. Notably, the closing of the public offering is not contingent on the private placement, providing flexibility but also uncertainty about the total capital raised.
